期刊文献+

姜黄素液晶纳米粒大鼠口服吸收的研究

Study on the oral absorption of curcumin-loaded liquid crystalline nanoparticles in rats
原文传递
导出
摘要 目的:研究姜黄素液晶纳米粒大鼠的口服吸收。方法:采用热处理-高压匀质法制备姜黄素液晶纳米粒,利用HPLC测定血浆中姜黄素浓度,DAS 2.0软件处理数据,求算药动学参数。结果:姜黄素液晶纳米粒口服吸收符合单室模型;与原料药组相比,姜黄素液晶纳米粒口服相对生物利用度为395.56%。结论:液晶纳米粒显著提高了姜黄素的口服吸收。 OBJECTIVE To study the oral absorption of curcumin-loaded liquid crystalline nanoparticles in rats.METHODS Curcumin loaded liquid crystalline nanoparticles were prepared with the method of hot treatment and high-pressure homogenization,curcumin in plasma was determined by HPLC and the results were analyzed with Program DAS 2.0 to obtain the pharmacokinetics parameters.RESULTS The oral absorption of curcumin loaded liquid crystalline nanoparticles in rat fitted one-compartment model,and the relative bioavailability was 395.56% compared to crude CUR.CONCLUSION Liquid crystalline nanoparticles could markedly improve the oral absorption of CUR in rat.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2012年第18期1423-1426,共4页 Chinese Journal of Hospital Pharmacy
基金 山东省科技攻关项目(编号:2010GWZ20203)
关键词 姜黄素 纳米粒 生物利用度 curcumin; nanoparticle; bioavailability;
  • 相关文献

参考文献8

  • 1Hossain DS, Bhattacharyya S, Das T, et al. Curcumin: The muhi-targeted therapy for cancer regression[J]. Front Biosci (Schol Ed) ,2012,4:335 -355.
  • 2Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanoformula- tions:a future nanomedicine for cancer[J]. Drug Discov To- day,2012,7(1-2) :71-80.
  • 3Lai J, Chen J, Lu Y, et al. Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems:I. In vitro e- valuation and enhanced oral bioavailability of the poorly water- soluble drug simvastatin[J]. AAPS Pharm Sci Tech, 2009, 10 (3) :960-966.
  • 4Boyd BJ,Khoo SM, Whittaker DV, et al. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats[J]. Int J Pharm,2007,340(1-2) :52-60.
  • 5Guo C, Wang J, Cao F, et al. Lyotropic liquid crystal systems in drug delivery[J]. Drug Discov Today, 2010, 15 (23-24) : 1032- 1040.
  • 6Garg G, Saraf S, Saraf S. Cubosomes: an overview [J]. Biol Pharm Bu11,2007,30 (2) :350-353.
  • 7Harde H,Das M,Jain S. Solid lipid nanoparticles: an oral bio- availability enhancer vehicle [J]. Expert Opin Drug Deliv, 2011,8 (11 ) : 1407-1424.
  • 8Kakkar V, Singh S, Singla D, et al. Exploring solid lipid nanop- articles to enhance the oral bioavailability of curcumin[J]. Mol Nutr Food Res,2011,55(3) :495-503.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部